Algernon Pharmaceuticals's total assets for Q3 2024 were C$3.89M, a decrease of -1.54% from the previous quarter. AGNPF total liabilities were C$1.93M for the fiscal quarter, a -45.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.